Weisheng Pharmaceutical is an innovative biomedical company focusing on endocrine-related treatment. It is committed to innovative treatments with more humane care so that endocrine patients can enjoy better treatment processes and curative effects to achieve the desired life. Weisheng puts patients' needs first and is committed to providing first-in-class (First in Class) or best-in-class (Best in Class) endocrine disease products and treatment solutions. Areas of treatment include adult endocrinology, pediatric endocrinology, and rare endocrine diseases. Weisheng continues to gather senior professionals with an international background, as well as technology and resources at the cutting edge of global innovation, to thoroughly lay out the Chinese market. It has set up offices in Shanghai, Beijing, Hong Kong, and Taipei to implement a full chain layout in the field of innovative endocrine drugs from R&D, production to sales, so that more Chinese endocrine patients can benefit from the world's cutting-edge and reliable treatment plans earlier.